As part of the ClearView Healthcare Partners leadership team, Philip works with clients to support decision-making and pursue strategic growth. His project experience includes all major therapeutic areas, providing broad perspective on opportunities for biopharmaceutical innovation.
Philip has 10 years of experience in biopharmaceutical-related research and consulting, and believes that strategy in the life sciences space requires a combination of scientific and clinical understanding paired with a strategic commercial perspective. He and his project teams work with clients to identify expected evolution in clinical paradigms, future competition, and reimbursement and regulatory dynamics to optimize decision-making across all phases of development and commercialization.
Philip earned his B.A. in biochemical sciences from Harvard University and received his M.Sc. in molecular medicine from University College London.
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
David Gilman
Ketan Kapadia
Philip Kenner
David McClain
Richard Mynahan
Kevin Richard
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Steve Rubman
Debbi Amanti Belanger
Kim Goh
Slater Hurst
Dave Konciak
Charles Mathews
Mike Rizzo
Mike Roy
Ryan Tubman
Beko Binder
Jonny Betts
Dean Griffiths
Maneesh Gujrati
Austin Hubbert
Jonathan Hodgson
Owen Im
Jonny Juliano
Andrew Kang
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian